Skov-Jeppesen SM et al., 2019: [Indications and application of extracorporeal shockwave therapy] (Original article only in Danish)

Skov-Jeppesen SM, Lundrup RN, Ladegaard PBJ, Mortensen J, Sørensen MD, Lund L.


Extracorporeal shockwave therapy (ESWT) is a novel treatment modality to stimulate tissue regeneration and anti-fibrosis. In this review, we summarise the use of ESWT for erectile dysfunction (ED), diabetic foot ulcers (DFU), Peyronie's disease (PD), chronic kidney disease (CKD), and scleroderma. Several randomised clinical trials demonstrate the efficacy of ESWT for vasculogenic ED and DFU, and ESWT may also relieve pain in patients with PD. ESWT is still experimental for CKD and scleroderma. In general, ESWT is associated with few and mild adverse effects.

Ugeskr Laeger. 2019 Feb 18;181(8). pii: V07180514. Danish.


Comments 1

Hans-Göran Tiselius on Monday, August 26 2019 08:20

Currently no comment available.

Currently no comment available.
Thursday, August 06 2020

By accepting you will be accessing a service provided by a third-party external to

Lohstampfestrasse 8
8274 Tägerwilen
Tel.: +41 (0)71 677 45 45
Fax: +41 (0)71 677 45 05